- Home
- MNPR vs PSTL Comparison
MNPR vs PSTL Comparison
Compare MNPR & PSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNPR | PSTL |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.0M | 487.7M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MNPR | PSTL |
|---|---|---|
| Price | $56.62 | $19.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $101.42 | $18.25 |
| AVG Volume (30 Days) | 305.3K | ★ 342.3K |
| Earning Date | 11-13-2025 | 02-25-2026 |
| Dividend Yield | N/A | ★ 5.23% |
| EPS Growth | N/A | ★ 508.95 |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $91,195,000.00 |
| Revenue This Year | N/A | $25.74 |
| Revenue Next Year | N/A | $14.38 |
| P/E Ratio | ★ N/A | $38.74 |
| Revenue Growth | N/A | ★ 26.65 |
| 52 Week Low | $26.06 | $12.26 |
| 52 Week High | $105.00 | $18.80 |
Technical Indicators
Market Signals| Indicator | MNPR | PSTL |
|---|---|---|
| Relative Strength Index (RSI) | 35.02 | 84.11 |
| Support Level | $60.00 | $17.57 |
| Resistance Level | $67.34 | $17.91 |
| Average True Range (ATR) | 4.84 | 0.39 |
| MACD | -0.92 | 0.09 |
| Stochastic Oscillator | 5.84 | 92.86 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.